sterile drug product facility
sterile drug product facility
BMS to Build $400M Biologics Facility in Dublin Boosting Manufacturing Capacity
BIOT
📢 Bristol Myers Squibb (BMS) invests $400M in a new sterile drug product facility in Dublin, Ireland. 🌍💪🧪🔬 Expected completion: 2026.
